Clinical Research | Magellan Rx Management

Website changes Our website will be sunsetting on December 2nd, 2024. Please visit our new home at PrimeTherapeutics.com.

Go Now

We are focused on harnessing the power of our valuable data and extensive clinical knowledge to bring the marketplace industry-leading research that can be a catalyst to improve health outcomes.

Utilization and Adherence Rates to Pulmonary Arterial Hypertension Medications

Comparison of New Start Antipsychotic LAI Members and Members Non-Adherent to an Oral Regimen

Academic Detailing Program Reduces Polypharmacy in a Managed Medicaid population

Academic Detailing Program Reduces Gaps in Care Within Medicaid Population

The Impact of Direct Outreach Programs on Provider Prescribing Patterns Related to Medication Adherence of Antipsychotic Medications

The Impact of Removing Prior Authorization Requirements for Second Generation Long Acting Injectable Antipsychotics for Prescribers in a Community Mental Health Center

The Impact of Direct Outreach Programs on Provider Prescribing Patterns in the Mid-West

Pharmacist Run Academic Detailing Behavioral Health Polypharmacy Program Delivers Positive Outcomes Within a Medicaid Population

Description of Adherence, Switches, and Discontinuations Among Statin Users in a Regional Medicare Health Plan

Predictive Versus Retrospective Analytics: Identification of Patients Who Are Non-adherent to Medication

Forecast Pharmacy Cost Using Demographics, Therapeutic Conditions and Historical Pharmacy Cost

Colorectal Cancer Treatment Patterns in Commercial, Medicare, and Medicaid Plans

Impact of a Clinical Outreach Program on the Utilization of High Risk Medications for CMS STAR Ratings

Real-World Antiemetic Utilization in Patients Undergoing Carboplatin Chemotherapy

Assess Out of Pocket Cost to Impact Medication Adherence for Patients with Autoimmune Disease Conditions

Real World Analysis of Health Plan Medical and Pharmacy Claims Data to Assess Differences in Healthcare Utilization and Total Cost in Patients Suffering from Cluster Headaches Compared with Patients without Headache-Related Conditions

Impact of Comprehensive Educational Outreach Program on NQF-Endorsed Clinical Performance Measures of Contraceptive Care in a Medicaid Population of Women of Childbearing Age with Mental Illness

Impact of Educational Outreach Program on Effective Contraceptive Use in Medicaid Women with Mental Illness

NYU Emergency Department Visit Classification Algorithm for Type 2 Diabetes Patients Before and After Diagnosis

Cost-effectiveness of an Early Diabetic Medication Adherence for New-starts

Real World Analyses of Patient Characteristics in Patients who Received a Retinal Eye Exam within the First Year of Type 2 Diabetes Mellitus Diagnosis Compared with Patients who did not Receive a Retinal Eye Exam

Results from a High-Touch Clinical Program to Improve Star Ratings Measure - Statin Use in Persons with Diabetes

Impact of a Clinical Outreach Program on Diabetes Treatment CMS STAR Rating

Evaluating the Relationship between a Diabetic Prevention Program (DPP) and Lowering the Risk for Type 2 Diabetes

Operationalizing the First FDA-Cleared Prescription Digital Therapeutic, reSET®, for Real World Implementation: Initial Pilot Methodology

Results from a High-Touch Clinical Program to Improve Star Ratings Measure: Statin Therapy for Patients with Cardiovascular Disease (SPC)

Real World Health Plan Data Analysis: Evaluating the Impact of Extended Half-Life Factor Products and Emicizumab-kxwh on Annualized Bleed Rate in Patients with Hemophilia

An Analysis on Utilization Trends and Potential Savings from Dose Optimization of Antihemophilic Factor Products Based on Ideal Body Weight

Impact of Smartphone-based Artificial Intelligence Platform on Hepatitis C Adherence in a Real-World Population

Real World Health Plan Data Analysis: Key Trends in Medication Adherence and Overall Costs in Patients with HIV

Analysis of a Pilot HIV Care Management Program

Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure

Real World Use of IVIG in US Regional Healthcare Plans

The Impact of Immunoglobulin Utilization Management and Dose Optimization in a Regional Health Plan

The Impact of Various Clinical Strategies on Achieving 5 Stars for the CMS Star Measure MTM Program Completion Rate for CMR

Impact of Various Clinical Strategies on the CMR Completion Rate for CMS STAR Ratings

Impact of a High-Touch Medication Therapy Management Program on Total Cost of Care

Real World Health Plan Data Analysis: Impact of Motivational Interviewing-Based Health Coaching on Adherence to Specialty Medications

Real World Analysis to Assess the Difference in Long-Term Medication Adherence and Persistence with Fingolimod Compared to Injectable Disease Modifying Therapies in Patients with Multiple Sclerosis

Real World Comparison of Patient Adherence and Persistence to Fingolimod vs. Dimethyl Fumarate in Multiple Sclerosis

A Retrospective Analysis of Real-World Medical Data to Evaluate Differences in Utilization and Expenditure of Natalizumab within Various Sites of Care

Retrospective Analysis of Real World Neurotoxin Utilization and Expenditures and Payer Perspectives on Management Opportunities in the U.S.

The Long-awaited Launch of Oncology Biosimilars: Evaluating the Impact of Payer and Provider Strategies on Early Adoption

Cost Savings Opportunity from Utilizing Less Costly Granulocyte Colony Stimulating Factors via Step Therapy

Dose Rounding Opportunity Analysis of Injectable Monoclonal Antibodies

Impact of Pharmacist Outreach and Intervention on Tyrosine Kinase Inhibitor (TKI) Adherence and Compliance to Response Testing in Patients with Chronic Myeloid Leukemia (CML)

Utilization Patterns and Adherence to TKIs and PCR Testing in Patients with CML in a Regional Health Plan

Cost of Care Initiative: Analyzing a Least Cost Alternative (LCA) Program with Specialty Ophthalmic Injections under the Medical Benefit

Ophthalmic Vascular Endothelial Growth Factor Inhibitors: First Year Single Eye Therapy Cost Evaluation Using Real-World Maintenance Frequency and Claim Costs for Aflibercept, Bevacizumab and Ranibizumab

Using Pharmacy Claims to Measure Opioid Misuse and Prospectively Identify At-Risk Patients

Clinical and Economic Impact of Relapse in Patients with Opioid Use Disorder in the US

A Real-World Analysis of Healthcare Cost and Utilization Among Patients Receiving Prescription Opioids and Identification of Potential Candidates for Opioid Discontinuation Therapy

Results from a High-Touch, Pharmacist-led Clinical Program to Reduce Opioid Utilization for At-Risk Beneficiaries

Evaluating the Relationship between Increased Patient Engagement and Adherence to Specialty Medications

The Impact of COVID-19 on the Proportion of Patients Utilizing Mail Order Versus Retail Pharmacies

Impacts of COVID-19 on the Adherence to Oral Anti-Diabetic Medications in Commercially Insured Adult Patients with Type 2 Diabetes Mellitus

The Emergence of Biosimilars for Oncology Treatment from a Payer’s Perspective

PCSK9-Inhibitor Persistence in a Medicare Population

Economic Model to Evaluate the Impact of Increased Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Rebates while also Reducing Prior Authorization Criteria

Reducing Rates of DPP-4i and GLP-1RA Co-Prescribing Using an Educational Letter Program

An Impact Analysis Comparing Two Outreach Methods Informing Members of a Cost Savings Alternative in a Commercially Insured Diabetic Population

Predictability Between a Diagnosis of Systolic Heart Failure and Guideline Recommended Therapies in a Medicare Population Using Pharmacy Claims Data and ICD-10 Codes

Impact of a Pharmacist Driven Outreach Program

Impact of Sofosbuvir on Utilization and Expenditure of Hepatitis C Medications in a Medicaid Population

Medication Therapy Management: Outcomes of Telephonic Pharmacist Outreach

Physician Acceptance of Pharmacist Recommendations With and Without Cytochrome DNA Testing Among Medicare Patients

Acute Opioid Prescribing Patterns and Trends Related to Conversion of Chronic Opioid Use in a Medicare PDP Population

Retrospective Analysis of Claims Utilization Data of Medications Indicated to Treat Osteoporosis in the Medicare Part D Population

Pharmacist Driven Shingrix Follow-Up, a Randomized Controlled Trial

Outcomes of Health Plan-Initiated Text-Based Medication Refill Reminders in Medicare Patients

HIV Pre-Exposure Prophylaxis: Adherence, Retention, and Discontinuation Rates Between Single and Multiple Tablet Regimens

Impacts of the COVID19 Pandemic on Adherence to Antidepressant Medications in Commercially Insured Adult Patients Receiving Pharmacotherapy for Depression

GLP-1 RA vs SGLT2i Adherence and Persistence in Commercially Insured Patients with Type 2 Diabetes Mellitus

Classification of Ozempic® and Victoza® Utilizers Into On-Label and Off-Label Cohorts

Exploring Utilization Trends of Recent Physician-Administered Biosimilar Launches

Real World Analysis of the Economic Impact of Infliximab Utilization by Site of Care and Medical Diagnosis within Two Regional Health Plans

Real World Analysis: Key Trends in Biologic Medication Adherence and Overall Costs and Outcomes in Patients with Rheumatoid Arthritis

Cost Savings Analysis from a Fully Implemented Site of Service (SOS) Management Program

Real-World Health Care Cost of Substance Abuse for Patients Receiving Face-to-Face Therapy vs. Without Therapy